Skip to main content
AAO-HNSF 2025 Annual Meeting & OTO EXPO Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Rate ePoster
Video

Facial Plastic and Reconstructive Surgery

(A418) Fresh Frozen Costal Cartilage for Rhinoplasty - An 8-year Experience

Monday, October 13, 2025
12:00 PM - 1:00 PM EDT
Location: OTO EXPO, Posters

    Presenting Author(s)

  • Richard Lu, MD, MBA, MSc

    Resident
    New York Presbyterian Hospital (Columbia Cornell Campus)
    New York, New York, United States

    • Co-Author(s)

  • Daniel Gamboa, BS

    Medical Student
    Weill Cornell Medical College
    New York, Florida, United States

    • Senior Author(s)

  • DP

    David Phillips, MD

    Assistant Professor of Otolaryngology/Head and Neck Surgery
    Weill Cornell Medicine
    New York, New York, United States

Disclosure(s):
Richard Lu, MD, MBA, MSc: No relevant relationships to disclose.
Daniel Gamboa, BS: No relevant relationships to disclose.
David Phillips, MD: No relevant relationships to disclose.


Introduction: Rhinoplasty often necessitates cartilage grafts to achieve desired structural and aesthetic outcomes. Traditional autologous grafts can result in increased operative times and secondary complications. Fresh-frozen costal cartilage (FFCC) graft has become a newer alternative, though few studies exist regarding their outcomes. This study evaluates one surgeon’s 8-year experience with fresh-frozen costal cartilage from M.T.F. Biologics for rhinoplasty.

Methods: We conducted a retrospective cohort study analyzing rhinoplasty procedures performed by a senior surgeon (D.J.P) from 2017 to 2024 at a tertiary academic center. Cohorts were defined by whether FFCC was used in rhinoplasty grafting. Primary outcomes assessed included postoperative infection rates and the rate of revision surgery. Data are controlled for patient factors such as age, gender, BMI, revision rhinoplasty, and type of grafting used.

Results: While data collection is ongoing, we are evaluating 400 rhinoplasties conducted over the past 8 years. We will report the rate of FFCC use as well as intra-operative indications for their use. We will also report the relative risk ratio for infection and need for revision surgery when using FFCC.

Conclusions: The use of FFCC in rhinoplasty procedures demonstrates comparable rates of infection and need for revision surgeries when compared to autologous cartilage grafts and cases without grafts. These findings suggest that FCCC allograft is a viable alternative to autologous cartilage, offering similar safety and efficacy profiles.